CIS
CLB icon

Capital International Sarl’s Core Laboratories CLB Stock Holding History

Capital International Sarl’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-73,150
Closed -$7.22M – 137
2017
Q3 		$7.22M Hold
73,150
– – 0.6% 56
2017
Q2 		$7.41M Buy
73,150
+4,700
+7% +$507K 0.64% 50
2017
Q1 		$7.91M Sell
68,450
-37,950
-36% -$4.41M 0.68% 43
2016
Q4 		$12.8M Buy
+106,400
New +$11.8M 1.17% 25

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Capital International Sarl's CLB Position: Q4 2017 in Review

Capital International Sarl sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 73,150 shares — an estimated $7.22M sold.

Capital International Sarl first reported a position in CLB in Q4 2016 and held it in 4 quarters. The position peaked at $12.8M in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Capital International Sarl reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Capital International Sarl sold 73,150 Core Laboratories shares in Q4 2017, an estimated $7.22M.
  • Capital International Sarl first reported a position in Core Laboratories in Q4 2016 and held it in 4 quarters.
  • Capital International Sarl's Core Laboratories position peaked at $12.8M in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Capital International Sarl's 13F filing for Q4 2017, filed 14 Feb 2018.